Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation. Kotsopoulos J, Gronwald J, Huzarski T, Aeilts A, et al. Breast Cancer Res Treat 2023 Jul 11. doi: 10.1007/s10549-023-06991.

Read + Share

Amedeo Smart

Independent Medical Education

Kotsopoulos J, Gronwald J, Huzarski T, Aeilts A, et al. Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation. Breast Cancer Res Treat 2023 Jul 11. doi: 10.1007/s10549-023-06991.
PMID: 37432545